COVID-19 Impact on CRISPR And CRISPR-Associated Genes Market, Global Research Reports 2020-2021

    • ID: AR2933506
    • 27 May, 2020
    • Other
    • Region: Global
    • 103 Pages
    • QYResearch

  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on CRISPR And CRISPR-Associated Genes Industry
  • 1.7 COVID-19 Impact: CRISPR And CRISPR-Associated Genes Market Trends
  • 2 Global CRISPR And CRISPR-Associated Genes Quarterly Market Size Analysis

    • 2.1 CRISPR And CRISPR-Associated Genes Business Impact Assessment - COVID-19
      • 2.1.1 Global CRISPR And CRISPR-Associated Genes Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global CRISPR And CRISPR-Associated Genes Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global CRISPR And CRISPR-Associated Genes Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, CRISPR And CRISPR-Associated Genes Headquarters and Area Served
    • 3.3 Date of Key Players Enter into CRISPR And CRISPR-Associated Genes Market
    • 3.4 Key Players CRISPR And CRISPR-Associated Genes Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on CRISPR And CRISPR-Associated Genes Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Genome Editing
      • 1.4.2 Genetic Engineering
      • 1.4.3 GRNA Database/Gene Librar
      • 1.4.4 CRISPR Plasmid
      • 1.4.5 Human Stem Cells
      • 1.4.6 Genetically Modified Organisms/Crops
      • 1.4.7 Cell Line Engineering
    • 4.2 By Type, Global CRISPR And CRISPR-Associated Genes Market Size, 2019-2021

    5 Impact of Covid-19 on CRISPR And CRISPR-Associated Genes Segments, By Application

    • 5.1 Overview
      • 5.5.1 Biotechnology Companies
      • 5.5.2 Pharmaceutical Companies
      • 5.5.3 Academic Institutes
      • 5.5.4 Research and Development Institutes
    • 5.2 By Application, Global CRISPR And CRISPR-Associated Genes Market Size, 2019-2021
      • 5.2.1 By Application, Global CRISPR And CRISPR-Associated Genes Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Thermo Fisher Scientific
      • 7.1.1 Thermo Fisher Scientific Business Overview
      • 7.1.2 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.1.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
    • 7.2 Editas Medicine
      • 7.2.1 Editas Medicine Business Overview
      • 7.2.2 Editas Medicine CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.2.4 Editas Medicine Response to COVID-19 and Related Developments
    • 7.3 Caribou Biosciences
      • 7.3.1 Caribou Biosciences Business Overview
      • 7.3.2 Caribou Biosciences CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.3.4 Caribou Biosciences Response to COVID-19 and Related Developments
    • 7.4 CRISPR therapeutics
      • 7.4.1 CRISPR therapeutics Business Overview
      • 7.4.2 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.4.4 CRISPR therapeutics Response to COVID-19 and Related Developments
    • 7.5 Intellia therapeutics, Inc.
      • 7.5.1 Intellia therapeutics, Inc. Business Overview
      • 7.5.2 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.5.4 Intellia therapeutics, Inc. Response to COVID-19 and Related Developments
    • 7.6 Cellectis
      • 7.6.1 Cellectis Business Overview
      • 7.6.2 Cellectis CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.6.3 Cellectis CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.6.4 Cellectis Response to COVID-19 and Related Developments
    • 7.7 Horizon Discovery Plc
      • 7.7.1 Horizon Discovery Plc Business Overview
      • 7.7.2 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.7.4 Horizon Discovery Plc Response to COVID-19 and Related Developments
    • 7.8 Sigma Aldrich
      • 7.8.1 Sigma Aldrich Business Overview
      • 7.8.2 Sigma Aldrich CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.8.4 Sigma Aldrich Response to COVID-19 and Related Developments
    • 7.9 Precision Biosciences
      • 7.9.1 Precision Biosciences Business Overview
      • 7.9.2 Precision Biosciences CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.9.4 Precision Biosciences Response to COVID-19 and Related Developments
    • 7.10 Genscript
      • 7.10.1 Genscript Business Overview
      • 7.10.2 Genscript CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.10.3 Genscript CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.10.4 Genscript Response to COVID-19 and Related Developments
    • 7.11 Sangamo Biosciences Inc.
      • 7.11.1 Sangamo Biosciences Inc. Business Overview
      • 7.11.2 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.11.4 Sangamo Biosciences Inc. Response to COVID-19 and Related Developments
    • 7.12 Lonza Group Limited
      • 7.12.1 Lonza Group Limited Business Overview
      • 7.12.2 Lonza Group Limited CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.12.4 Lonza Group Limited Response to COVID-19 and Related Developments
    • 7.13 Integrated DNA Technologies
      • 7.13.1 Integrated DNA Technologies Business Overview
      • 7.13.2 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.13.4 Integrated DNA Technologies Response to COVID-19 and Related Developments
    • 7.14 New England Biolabs
      • 7.14.1 New England Biolabs Business Overview
      • 7.14.2 New England Biolabs CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.14.4 New England Biolabs Response to COVID-19 and Related Developments
    • 7.15 Origene Technologies
      • 7.15.1 Origene Technologies Business Overview
      • 7.15.2 Origene Technologies CRISPR And CRISPR-Associated Genes Quarterly Revenue, 2020
      • 7.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Product Introduction
      • 7.15.4 Origene Technologies Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of CRISPR And CRISPR-Associated Genes, including the following market information:
      Global CRISPR And CRISPR-Associated Genes Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global CRISPR And CRISPR-Associated Genes Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global CRISPR And CRISPR-Associated Genes Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global CRISPR And CRISPR-Associated Genes Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Genome Editing
      Genetic Engineering
      GRNA Database/Gene Librar
      CRISPR Plasmid
      Human Stem Cells
      Genetically Modified Organisms/Crops
      Cell Line Engineering

      Based on the Application:
      Biotechnology Companies
      Pharmaceutical Companies
      Academic Institutes
      Research and Development Institutes



      Summary:
      CRISPR And CRISPR-Associated Genes Market Research Report is about CRISPR And CRISPR-Associated Genes Industry study. Get complete CRISPR And CRISPR-Associated Genes market research report published after Market Study, Industrial Analysis with Trends & Statistics. CRISPR And CRISPR-Associated Genes Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED